| Home |
| Business |
| Sciences |
| Regulatory & IPR |
| Market Studies |
| Open Source |
| News in Brussels |
| Technological partnership |
| European opportunities |
| IPR Support |
| Strategic Information |
| Bio&Pharma e-Newsletter |
| Legal note |
| Bio&Pharma Companies |
| Bio&Pharma Universities |
| Bio&Pharma Organisations |
| BEA-ABE-BAO |
| MedTech Universities |
| MedTech Organisations |
| MedTech Companies |
Wednesday, 24 March 2010
A special issue of the OECD Journal, entitled "Agricultural and health biotechnologies: Building blocks of the bioeconomy”, has been published. It contains articles originally prepared for the Bioeconomy to 2030 project to provide evidence-based projections on the development of biotechnologies – the building blocks of the bioeconomy – up to 2015 in agriculture and health.
What China's healthcare reforms mean for pharma
Monday, 14 December 2009
A new eyeforpharma report outlines the challenges and opportunities in the fast-changing Chinese market. After much deliberation, the Chinese government has clarified the scope of healthcare reforms and implementation is already underway in some areas. The changes, which are designed to broaden access and reduce the cost of medical care, will have broad impacts on how pharma does business across this vast nation. But industry executives surveyed by eyeforpharma say companies are still formulating appropriate new strategies.
The OECD Biotechnology Statistics 2009
Wednesday, 08 July 2009
The 2009 edition brings together the latest available economic and activity data on biotechnology and innovation for 22 OECD members and four non-member countries. It builds on the extensive work of the OECD and national experts to improve the comparability of biotechnology statistics.
Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing& Sales& Marketing
Monday, 23 March 2009
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector.
Saturday, 01 November 2008
This Kalorama market study of the blood industry provides an analysis of all the key market segments involved in this industry, including products, equipment and testing.
<< Start < Prev 1 2 3 4 5 Next > End >>
Results 1 - 9 of 43